Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jun 13;14(6):12458-83.
doi: 10.3390/ijms140612458.

The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice

Domenico De Berardis  1 , Stefano Marini, Michele Fornaro, Venkataramanujam Srinivasan, Felice Iasevoli, Carmine Tomasetti, Alessandro Valchera, Giampaolo Perna, Maria-Antonia Quera-Salva, Giovanni Martinotti, Massimo di Giannantonio
Affiliations
Review

The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice

Domenico De Berardis et al. Int J Mol Sci. .

Abstract

Melatonin exerts its actions through membrane MT1/MT2 melatonin receptors, which belong to the super family of G-protein-coupled receptors consisting of the typical seven transmembrane domains. MT1 and MT2 receptors are expressed in various tissues of the body either as single ones or together. A growing literature suggests that the melatonergic system may be involved in the pathophysiology of mood and anxiety disorders. In fact, some core symptoms of depression show disturbance of the circadian rhythm in their clinical expression, such as diurnal mood and other symptomatic variation, or are closely linked to circadian system functioning, such as sleep-wake cycle alterations. In addition, alterations have been described in the circadian rhythms of several biological markers in depressed patients. Therefore, there is interest in developing antidepressants that have a chronobiotic effect (i.e., treatment of circadian rhythm disorders). As melatonin produces chronobiotic effects, efforts have been aimed at developing agomelatine, an antidepressant with melatonin agonist activity. The present paper reviews the role of the melatonergic system in the pathophysiology of mood and anxiety disorders and the clinical characteristics of agomelatine. Implications of agomelatine in "real world" clinical practice will be also discussed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanism of action of agomelatine (adapted from Srinivasan et al. [105]).
See this image and copyright information in PMC

References

    1. Wurtman R.J., Larin F., Axelrod J., Shein H.M., Rosasco K. Formation of melatonin and 5-hydroxyindole acetic acid from 14C-tryptophan by rat pineal glands in organ culture. Nature. 1968;217:953–954. - PubMed
    1. Cardinali D.P., Pévet P. Basic aspects of melatonin action. Sleep. Med. Rev. 1998;2:175–190. - PubMed
    1. Hardeland R., Cardinali D.P., Srinivasan V., Spence D.W., Brown G.M., Pandi-Perumal S.R. Melatonin—A pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 2011;93:350–384. - PubMed
    1. Pévet P. Melatonin. Dialogues Clin. Neurosci. 2002;4:57–72. - PMC - PubMed
    1. Stehle J.H., von Gall C., Korf H.W. Melatonin: A clock-output, a clock-input. J. Neuroendocrinol. 2003;15:383–389. - PubMed